doi: 10.1016/j.ijantimicag.2017.08.014 17 GaoM.MonianP.QuadriN.RamasamyR.JiangX
TNFSF14 inhibits melanogenesis via NF-kB signaling in melanocytes
Patients should understand their own risk factors, medication schedules, and treatment goals
& Freeman, M
#healthtech #obesitycare #servicedesign #nhs To view or add a comment, sign in GLP-1s Are Not Miracle Drugs Theyre Powerful Tools When Used Correctly Key takeaways from this timely National Academy of Medicine discussion: - GLP-1based therapies can be highly effective, but expectations must align with the evidence - Obesity is a chronic disease, not a short-term condition solved by medication alone - Safety, access, and cost remain central challenges - Medications work best when embedded in comprehensive, wraparound care - Addressing stigma is as important as addressing biology Grateful to be part of this thoughtful conversation moderated by Alex Azar, with Govind Persad, Jeffrey Singer, and Tracy Zvenyach, PhD, MS, RN #GLP1 #ObesityCare #PublicHealth #HealthPolicy Are GLP-1 drugs miracle medications, or are expectations getting ahead of the evidence
GIP and GLP-1, the two incretin hormones: similarities and differences: similarities and differences of GIP and GLP-1
